D-0543-2023 Class II

Recalled by Baxter Healthcare Corporation — Deerfield, IL

FDA drug recall D-0543-2023 was initiated by Baxter Healthcare Corporation on Mar 15, 2023 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component. Affected quantity: 9,788 bags.

Recall details

Product Type
Drugs
Report Date
May 3, 2023
Initiation Date
Mar 15, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9,788 bags

Product description

Dianeal PD-2 Peritonial Dialysis Solution with 1.5% Dextrose, 3000 mL per Ambu-Flex II Container bag, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA. Product Code L5B5169, NDC 0941-0411-04.

Reason for recall

Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.

Distribution pattern

Nationwide in the USA

Code information

Lot Y405201, Exp 31-Oct-2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0543-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0543-2023. Report a data issue: hello@regdatalab.com.